Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is miscarriage a coagulopathy?

Raj Rai1

  • 1Department of Obstetrics and Gynecology, Imperial College London, St Mary's Hospital, London, UK. r.rai@imperial.ac.uk

Current Opinion in Obstetrics & Gynecology
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation and comparison of semen microbiota and bacterial load in men with infertility, recurrent miscarriage, or proven fertility.

eLife·2025
Same author

The Role of Seminal Oxidative Stress in Recurrent Pregnancy Loss.

Antioxidants (Basel, Switzerland)·2023
Same author

Design of Smart Nanodiamonds: Introducing pH Sensitivity to Improve Nucleic Acid Carrier Efficiency of Diamoplexes.

Pharmaceutics·2022
Same author

Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery.

Pharmaceutics·2021
Same author

Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.

Lancet (London, England)·2021
Same author

Recurrent miscarriage: evidence to accelerate action.

Lancet (London, England)·2021
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Recurrent miscarriage may stem from a defective maternal blood clotting response, leading to pregnancy complications. Identifying women at risk for miscarriage due to thrombophilia is crucial for effective management.

Area of Science:

  • Reproductive Medicine
  • Hematology
  • Obstetrics

Background:

  • Pregnancy naturally induces a hypercoagulable state.
  • Recurrent miscarriage and later pregnancy complications may be linked to maternal hemostatic defects.
  • These defects can lead to uteroplacental vascular thrombosis and fetal loss.

Purpose of the Study:

  • To review evidence supporting the hypothesis that defective maternal hemostasis causes recurrent miscarriage and pregnancy complications.
  • To explore the link between thrombophilia and adverse pregnancy outcomes.

Main Methods:

  • Literature review of studies on recurrent miscarriage and thrombophilia.
  • Analysis of evidence linking genetic thrombophilic mutations to pregnancy loss.
  • Examination of studies on pre-pregnancy prothrombotic states and their impact.

Related Experiment Videos

Main Results:

  • Most studies show increased prevalence of genetic thrombophilic mutations in women with recurrent miscarriage.
  • A subset of women with recurrent miscarriage exhibits a pre-pregnancy prothrombotic state.
  • This prothrombotic state increases the risk of future miscarriage.
  • Long-term health implications include increased risk of ischemic heart disease after pregnancy loss.

Conclusions:

  • Recurrent miscarriage is heterogeneous; no single cause fits all cases.
  • The link between hemostatic abnormalities and pregnancy outcomes is increasingly recognized.
  • Challenges include identifying at-risk women, understanding pregnancy loss pathology, the fetal genotype's role, and long-term management of thrombophilic defects.